text
text

We Invest in Drug Development Companies *

We believe these investment opportunities offer both substantial risk-adjusted returns as well as paradigm-changing therapeutics for patients and for society.

*Securities highlighted or discussed above have been selected to illustrate Aquilo Capital Management, LLC’s (“Aquilo”) investment approach and/or market outlook and are not intended to represent the performance of Aquilo’s clients or indicator for how Aquilo’s clients have performed or may perform in the future. Each listed security was selected purposefully for this purpose and has not been selected on the basis of performance or any performance-related criteria. The securities discussed herein do not represent an entire portfolio and in the aggregate may only represent a small percentage of a clients’ holdings. Aquilo’s clients’ portfolios are actively managed and securities discussed may or may not be held in such portfolios at any given time. Nothing on this webpage shall constitute a recommendation or endorsement to buy or sell any security or other financial instrument referenced herein.

text

We Translate Opportunities Into Scientific Breakthroughs